0001654954-22-000128.txt : 20220104 0001654954-22-000128.hdr.sgml : 20220104 20220104143121 ACCESSION NUMBER: 0001654954-22-000128 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220101 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tsuchimoto Kim R CENTRAL INDEX KEY: 0001333516 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 22505293 MAIL ADDRESS: STREET 1: C/O MONOPAR THERAPEUTICS INC. STREET 2: 1000 SKOKIE BLVD., SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2022-01-01 false 0001645469 Monopar Therapeutics MNPR 0001333516 Tsuchimoto Kim R 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 false true false false Chief Financial Officer Common Stock 2022-01-01 4 M false 1231 A 5420 D Common Stock 2022-01-01 4 F false 505 3.21 D 4915 D Restricted Stock Units 2022-01-01 4 M false 1231 0 D Common Stock 1231 2461 D Represents shares acquired on vesting and settlement of restricted stock units. On January 31, 2020 the reporting person was granted 4,923 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. /s/ Kim R. Tsuchimoto 2022-01-04